CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The A CACTUS project aims to develop a novel method for detecting circulating tumor cells (CTCs) based on their metabolic features rather than antibody labeling. This approach allows for the identification of both epithelial and non-epithelial cancer cells, which is critical for improving cancer treatment.
The problem:
Cancer metastases are responsible for 90% of cancer-associated deaths.
Circulating tumour cells (CTCs) that enter the blood stream on their way to potential metastatic sites are of obvious interest to evaluate correctly patient treatment and therefore influence outcome. CTCs have been identified in bladder, gastric, prostate, lung, breast and colon cancer.
The only FDA approved CTCs detection system is Veridex’ CellSearch, which detects only epithelial cancer cells using antibody la…
UNIVERSITA DEGLI STUDI DI UDINE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
